Senate Appropriations Subcommittee Reviews Proposed FY2010 Budget
On May 21, the Senate Committee on Appropriations’ Subcommittee on Labor, Health and Human Services, Education, and Related Agencies held a hearing to examine the President’s proposed fiscal year 2010 budget for NIH and to discuss the $10.4 billion provided to NIH in the American Recovery and Reinvestment Act. NIH Acting Director Dr. Raynard Kington, NIAID Director Dr. Anthony Fauci, NHLBI Director Dr. Elizabeth Nabel, and NCI Director Dr. John Niederhuber testified.
Senator Tom Harkin (D-IA), chairman of the Subcommittee, expressed concerns about how Recovery Act funds were being spent and what happens after funding runs out in 2011. Dr. Niederhuber testified that Recovery Act funds were allowing NCI to advance projects in early phase translational research and to expand The Cancer Genome Atlas project to include additional cancer sites, beyond glioblastoma, ovarian cancer, and lung cancer.
Due to the strong interest in the challenge grants, Senator Harkin was concerned that fewer than 5 percent would be funded. Dr. Kington predicted that NIH would more than double its initial commitment of $200 million, allowing the agency to fund a greater number of challenge grants. Dr. Kington also noted that every institute and center at NIH funds research related to cancer, and NIH has initiated a strategic planning process co-chaired by Dr. Niederhuber and Dr. Stephen Katz, director of NIAMS and a senior investigator at NCI.
For more information about this and other NCI congressional activity, visit the NCI Office of Government and Congressional Relations’ Web site.